Skip to main content
Clinical Trials/TCTR20220708002
TCTR20220708002RecruitingNot Applicable

Effect of Oral Magnesium Supplementation on Phosphate Level and Kidney Function in Children with Hyperphosphatemia: A Randomized Double-Blinded Placebo-Controlled Clinical Trial

Dr Soetomo General Hospital0 sites60 target enrollmentStarted: July 8, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
2 Years to 18 Years (—)
Sex
All

Inclusion Criteria

  • •phosphate level above 6.51 mg/dL (age 2-5 years old); above 5.8 mg/dL (age 6-12 years old); or above 4.6 mg/dL (age 13-18 years old)

Exclusion Criteria

  • •1. currently on hemodialysis or peritoneal dialysis
  • •2. estimated glomerular filtration rate less than 15 ml/min/1.73 m2
  • •3. serum magnesium level above 2.5 mg/dL
  • •4. allergic to magnesium supplementation
  • •5. history of severe gastrointestinal disease

Investigators

Sponsor
Dr Soetomo General Hospital

Similar Trials